PMID: 9540951Apr 16, 1998Paper

Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents

Obstetrics and Gynecology
C M O'DellG Slap

Abstract

To compare rates of method continuation and repeat pregnancy among postpartum adolescents selecting depot medroxyprogesterone acetate or oral contraceptives (OCs). A retrospective study of 161 adolescents aged 19 years and younger who gave birth at an urban teaching hospital between May 1, 1994, and April 30, 1995, returned to the hospital's family planning clinic within 14 weeks of delivery and chose depot medroxyprogesterone acetate (n=111, 69%), or OC (n=50, 31%) as their postpartum contraceptive method. Most subjects were black (99%), single (97%), and on medical assistance (85%). Data were gathered 12-18 months postpartum (mean+/-standard deviation [SD] 14.5+/-1.6 months) by telephone interview and medical record review. The main outcome measures were method continuation and repeat pregnancy. The mean (+/-SD) age at delivery was 17.8+/-1.4 years. Variables differentiating subjects selecting depot medroxyprogesterone acetate or OC included multiparity (34% versus 12%, P < .05), mean age at first pregnancy (15.9 versus 16.6 years, P < .05), and mean age at first delivery (16.1 versus 16.9 years, P < .05). The survival curves for depot medroxyprogesterone acetate and OC continuation differed significantly (median duration of ...Continue Reading

References

Mar 1, 1990·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·C Stevens-SimonE R McAnarney
Nov 1, 1989·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·M L Balassone
May 1, 1995·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·C Stevens-SimonJ Allen-Davis
May 1, 1995·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Z HarelL M Kollar
Apr 1, 1995·American Journal of Obstetrics and Gynecology·A B Berenson, C M Wiemann
Nov 1, 1994·Contraception·P D BlumenthalG R Huggins
Nov 3, 1994·The New England Journal of Medicine·M PolaneczkyS Sondheimer
Aug 1, 1996·Obstetrics and Gynecology·H Sangi-HaghpeykarJ R Ditmore
Aug 1, 1996·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Z HarelJ L Rauh

❮ Previous
Next ❯

Citations

Dec 5, 2000·Contraception·E EspeyC Qualls
Dec 22, 2000·Contraception·P Chotnopparatpattara, S Taneepanichskul
Mar 15, 2000·Contraception·D HubacherD Taylor
Apr 25, 2000·Obstetrics and Gynecology·C L TemplemanS P Hertweck
Mar 15, 2003·Obstetrics and Gynecology·Maarit PaukkuTina Raine
Sep 24, 1999·Pediatric Clinics of North America·Z Harel, B Cromer
Aug 26, 1998·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·M Polaneczky, M Liblanc
Sep 4, 1999·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·P J Flanagan, Z Harel
May 24, 2000·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·C Stevens-SimonJ Wallis
Mar 13, 2002·Journal of Pediatric and Adolescent Gynecology·Therese M ZinkThomas Buchanan
Mar 23, 2011·Obstetrics and Gynecology·Andrea E BonnyBarbara Cromer
Dec 7, 2002·International Journal of Adolescent Medicine and Health·Hatim OmarSandy D'Angelo
Feb 24, 2006·Paediatric Drugs·Rollyn M Ornstein, Martin M Fisher
Mar 31, 2004·Journal of Pediatric and Adolescent Gynecology·Andrea E BonnyGail B Slap
Aug 17, 2011·Contraception·Maryam GuiahiKimberly Kenton
Apr 7, 2010·Best Practice & Research. Clinical Obstetrics & Gynaecology·Sam Rowlands
Apr 10, 2007·Journal of Pediatric and Adolescent Gynecology·Andrea Ries ThurmanMary Ellen Roddy
Dec 23, 2006·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Andrew M Kaunitz
Mar 16, 2007·Perspectives on Sexual and Reproductive Health·Leslie G Raneri, Constance M Wiemann
May 4, 2004·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Lori A BoardmanKate L Lapane
May 30, 2006·Contraception·Carla Picardo
Apr 24, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Amanda BlackAnne Marie Whelan
Apr 24, 2016·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Amanda BlackAnne Marie Whelan
Apr 16, 1999·American Journal of Obstetrics and Gynecology·P D DarneyA M Robert
Aug 17, 2010·Journal of Pediatric and Adolescent Gynecology·Andrea E BonnyBarbara A Cromer
Sep 22, 1998·Archives of Pediatrics & Adolescent Medicine·C Stevens-Simon, L Kelly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.